Cinda Biotech rose more than 10% to HK$112.70 in the intraday market, a record high. The company previously announced a 45% year-on-year increase in revenue for the first half of the year to RMB 8.6 billion. Although total revenue fell short of estimates, Nomura said net profit growth exceeded expectations.

Cinda Biotech rose more than 10% to HK$112.70 in the intraday market, a record high. The company previously announced a 45% year-on-year increase in revenue for the first half of the year to RMB 8.6 billion. Although total revenue fell short of estimates, Nomura said net profit growth exceeded expectations.